摘要
多药耐药基因(MDR1)多态性是影响肿瘤患者对化疗药物反应的重要遗传因素,也与患者对疾病的易感性及临床表现有关。该文就近年来对MDR1基因多态性与肿瘤临床关系的研究作一综述。
出处
《国际检验医学杂志》
CAS
2006年第8期736-738,共3页
International Journal of Laboratory Medicine
参考文献16
-
1Jamroziak K,Mlynarski W,Balcerczak E,et al.Functional C3435T polymorphism of MDR1 gene:an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.Eur J Haematol,2004,72(5):314-321.
-
2Kishi S,Yang W,Boureau B,et al.Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.Blood,2004,103(1):67-72.
-
3Plasschaert SL,Groninger E,Boezen M,et al.Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.Clin Pharmacol Ther,2004,76(3):220-229.
-
4Illmer T,Schuler US,Thiede C,et al.MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.Cancer Res,2002,62(17):4955-4962.
-
5van-den-Heuvel-Eibrink MM,Wiemer EA,de-Boevere MJ,et al.MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.Blood,2001,97(11):3605-3611.
-
6Efferth T,Sauerbrey A,Steinbach D,et al.Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.Int J Oncol,2003,23(2):509-517.
-
7Kaya P,Gunduz U,Arpaci F,et al.Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients.Am J Hematol,2005,80(1):26-34.
-
8Potocnik U,Ravnik-Glavac M,Golouh R,et al.Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene:correlation with microsatellite instability and lymphoid infiltration in colorectal cancers.J Med Genet,2002,39(5):340-346.
-
9Taniguchi S,Mochida Y,Uchiumi T,et al.Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon.Mol Cancer Ther,2003,2(12):1351-1359.
-
10Humeny A,Rodel F,Rodel C,et al.MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry.Anticancer Res,2003,23(3B):2735-2740.
同被引文献64
-
1芮萌,李龙芸,刘丽华.肺癌组织中P-gp、MRP、p53蛋白的表达及其临床意义[J].海军总医院学报,2003,16(4):201-205. 被引量:4
-
2岑宇翔,陆志诚,汪华侨,陈盛强.汉族人MDR1 C3435T基因的多态性[J].解剖学研究,2004,26(1):11-13. 被引量:16
-
3莫让伟,刘长安.肝癌相关性基因研究现状[J].国际检验医学杂志,2006,27(11):1023-1025. 被引量:2
-
4王威,仇玉兰,孙品,夏昭林.几种常规实验室适用的单核苷酸多态性检测方法原理与应用[J].职业卫生与应急救援,2006,24(4):177-179. 被引量:5
-
5Shi MM, Technology for individual genotyping: detection of genetic polymorphisms in drug targets and disease gene[J]. Am J Pharmacogenomics ; 2002,2 (3) 197- 205.
-
6Carcorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects[J]. Clin Pharmacol Ther,2001,69(2) : 168-174.
-
7Ji YT, Qu CQ, Cao BY. An optimal method of DNA silver staining in polyacrylamide gels [J]. Electrophoresis, 2007,28 (8) : 1173-1175.
-
8Vincenzo I, Maria AC, Renata DF, et al. Electrophoresis of protein and DNA on horizontal sodium dodecyl sulfate polyacrylamide gels[J]. Immunity & Ageing,2006,3(1) :7-12.
-
9Li Y, Wang Y, Sun J, et al. Distribution of the functional MDR1C3435T polymorphism in the Han population of China [J]. Swiss Med Wkly,2006,136(8):377- 382.
-
10Carcorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther, 2001, 69 (3): 169-174.
引证文献4
-
1徐建业,周琦,马丽芳,吴立翔.聚丙烯酰胺凝胶DNA水平电泳检测多药耐药基因多态性[J].国际检验医学杂志,2008,29(12):1091-1092. 被引量:1
-
2马丽芳,周琦,徐建业,李少林.DNA水平电泳检测重庆地区汉族人MDR1C3435T基因多态性[J].中国生物制品学杂志,2009,22(9):927-929.
-
3余宗涛,高琼,高波,吕军,张吉才.非小细胞肺癌中肺耐药蛋白的表达及与临床病理特征的关系[J].国际检验医学杂志,2012,33(9):1042-1044. 被引量:6
-
4吴洁,张卿.肺癌耐药机制的分子学进展[J].内蒙古医学杂志,2014,46(2):177-180.
二级引证文献7
-
1马丽芳,周琦,徐建业,李少林.DNA水平电泳检测重庆地区汉族人MDR1C3435T基因多态性[J].中国生物制品学杂志,2009,22(9):927-929.
-
2吴玉竹,骆海军,王鹏,刘跃.非小细胞肺癌中BCRP mRNA表达的临床意义[J].现代检验医学杂志,2013,28(2):63-65.
-
3梁燕,张莹,贾英杰.非小细胞肺癌多药耐药机制研究进展[J].山东医药,2013,53(35):102-104. 被引量:6
-
4李杰,龚民,崔永,李浩,常栋,林昌锦,高志,胡健,王天佑.肺耐药蛋白LRP在肺癌中的表达及意义[J].现代肿瘤医学,2014,22(12):2875-2879. 被引量:5
-
5常丽,林红,孙素芹,庞有铨,边楠楠,甄春英,关雪晴,杨浩,刘雪梅.核苷酸切除修复交叉互补组1和肺耐药蛋白不同表达水平对顺铂治疗恶性胸腔积液的影响[J].结核病与肺部健康杂志,2019,8(3):178-182. 被引量:1
-
6刘雪梅,常丽,庞有铨,边楠楠,甄春英,关雪晴,杨浩,林红.ERCC1和LRP表达水平指导恶性胸腔积液的精准医疗[J].黑龙江医学,2019,43(12):1431-1434. 被引量:1
-
7李凤玲,张卿.非小细胞肺癌耐药机制新进展[J].世界最新医学信息文摘,2016,0(26):39-40. 被引量:1
-
1蔡辉,乔成钢,郭天康,李荣范,达明绪,李安强,郝相勇.槲皮素联合survivin反义核苷酸对肝癌细胞凋亡协同作用的研究[J].中华普通外科杂志,2010,25(5):409-413. 被引量:3
-
2杜红心,罗海峰,彭必江,陈蓉,程钢,林岚.3项肿瘤标志物联合检测对肝癌诊断的临床应用价值[J].国际检验医学杂志,2010,31(3):274-275. 被引量:3
-
3林肖鹰,陈小岩,陈志忠.非小细胞肺癌组织ERCC1和RRM1表达及其临床预后的相关性研究[J].福建医科大学学报,2011,45(1):10-14. 被引量:4
-
4王晋.抗结核治疗合并HBV感染的结核病患者肝损害的发生及其临床治疗的探讨[J].现代诊断与治疗,2016,27(3):494-495. 被引量:2
-
5欧阳昕(综述),戴勇(综述).单核苷酸多态性与系统性红斑狼疮易感性研究进展[J].国际泌尿系统杂志,2010,30(2):245-248. 被引量:2
-
6王淼,李用国.核苷(酸)类似物治疗慢加急性肝衰竭研究进展[J].临床肝胆病杂志,2012,28(5):391-394. 被引量:1
-
7纪庆松.核苷类药物在乙肝治疗过程的相关问题[J].中国中医药咨讯,2010(17):266-266.
-
8刘文华,杨湛,应若素.核苷(酸)类似物停药后复发及长期用药的安全性[J].国际流行病学传染病学杂志,2015,42(3):205-207.
-
9张兴文.病毒性脑炎76例临床诊断与治疗分析[J].中国现代医生,2010,48(5):140-141. 被引量:1
-
10潘如燕,冯一中.三阴性乳腺癌的临床病理特征及免疫组化标记[J].齐齐哈尔医学院学报,2013,34(23):3528-3529.